Croup as a Manifestation of SARS-CoV-2 Omicron Variant Infection in Young Children

Youn Young Choi1, You Sun Kim1, Seong Yong Lee2

  • 1Department of Pediatrics, National Medical Center, Seoul, Korea.

Insights

Young children with COVID-19, particularly during the omicron surge, showed a significant increase in croup cases. Early diagnosis and treatment of croup symptoms in children are crucial for managing coronavirus disease 2019.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Respiratory Medicine

Background:

  • Croup, an acute upper airway disease, is typically caused by parainfluenza virus, presenting with barky cough and stridor in children.
  • Inflammation and edema of the upper airways characterize croup, potentially leading to respiratory distress in affected children.

Purpose of the Study:

  • To investigate the incidence of croup in children under 5 years old with coronavirus disease 2019 (COVID-19) during the omicron surge.
  • To compare the proportion of croup cases during the omicron wave versus the delta wave in pediatric COVID-19 patients.

Main Methods:

  • Retrospective analysis of 569 children under 5 years old admitted with COVID-19 to two Seoul hospitals between March 1, 2021, and February 25, 2022.
  • Comparison of croup case proportions during the omicron and delta waves of the COVID-19 pandemic.

Main Results:

  • A total of 21 children (3.7%) were diagnosed with croup among the hospitalized COVID-19 patients.
  • The proportion of croup cases was significantly higher during the omicron wave (12.4%) compared to the delta wave (1.2%) (P < 0.001).
  • Rapid symptom improvement was observed following the administration of corticosteroids and nebulized epinephrine.

Conclusions:

  • The omicron surge was associated with a notable increase in croup cases among young children with COVID-19.
  • Close monitoring for croup symptoms in children is essential for the timely diagnosis and management of COVID-19.
  • Prompt treatment with corticosteroids and epinephrine can effectively manage croup symptoms in pediatric COVID-19 patients.

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
582
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
1.8K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
672
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
961
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.1K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
394